跳至主要内容
临床试验/NCT00917696
NCT00917696已完成1 期

A Randomized, Double Blind, Placebo Controlled, Crossover Clinical Trial to Evaluate the Effects of ATP-Induced Pain (AIP) and ATP-induced Dermal Vasodilation (AIDV) by Iontophoresis in Healthy Subjects

Merck Sharp & Dohme LLC0 个研究点目标入组 44 人开始时间: 2009年10月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
44
主要终点
Degree of pain induced by ATP vs. saline iontophoresis

研究概览

简要总结

This study will evaluate ATP-induced Pain (AIP) and ATP-induced dermal vasodilation (AIDV) as target engagement tools for future development of analgesics.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Diagnostic
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Subject is in generally good health
  • Subject is willing to abstain from smoking within 24 hours of each iontophoresis treatment and limit smoking to 5 or less cigarettes per week during the study

排除标准

  • Subject has a history of dermatitis, psoriasis, or eczema
  • Subject has active asthma and/or hay fever at the time of the screening visit
  • Subject is unable to refrain from use of analgesics within 3 days prior to each treatment period

结局指标

主要结局

Degree of pain induced by ATP vs. saline iontophoresis

时间窗: 4 minutes

Increase in blood flow induced by ATP iontophoresis

时间窗: 8 minutes

次要结局

  • Test-retest reproducibility and intra-subject variability of AIP and AIDV(8 minutes)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验